Current role
Biotechnology · Healthcare
Board Member
2025-05-22–present
Jane Wasman
Board Member
Rigel Pharmaceuticals Inc (RIGL)Equibles does not estimate personal net worth.
Get an email with a short summary when Rigel Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get RIGL alertsAbout Jane Wasman
Jane Wasman is recorded as Board Member at Rigel Pharmaceuticals Inc (RIGL) since May 22, 2025. Rigel Pharmaceuticals Inc reported in an 8-K filed May 23, 2025 that Jane Wasman was appointed director, effective May 22, 2025. Rigel Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rigel Pharmaceuticals Inc includes Raul R. Rodriguez (CEO and Board Member), Raul Rodriguez (CEO and Board Member), Dean Schorno (CFO) and 7 others.
“Each of the nominees for director, to serve until the Company's 2028 Annual Meeting of Stockholders or until his or her respective successor has been elected and qualified, was elected as follows:”
Affiliation history
-
Current
2025-05-22–present
Company network
Leadership on record at Rigel Pharmaceuticals Inc
- Raul R. Rodriguez CEO, Board Member
- Raul Rodriguez CEO, Board Member
- Dean Schorno CFO
- Raymond Furey General Counsel
- Alison Hannah Board Member
- Alison Hannah, M.D. Board Member
- Alison L. Hannah Board Member
- Brian L. Kotzkin Board Member
- Gary A. Lyons Board Member
- Gregg A. Lapointe Board Member